|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 26, No 8 (March 10), 2008: pp. 1269-1274 © 2008 American Society of Clinical Oncology. DOI: 10.1200/JCO.2007.14.2661 The Body Image and Relationships Scale: Development and Validation of a Measure of Body Image in Female Breast Cancer Survivors
From the Department of Psychology; Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA; Division of Epidemiology and Community Health; and College of Pharmacy and School of Nursing, University of Minnesota, Minneapolis, MN Corresponding author: Kathryn H. Schmitz, PhD, 921 Blockley Hall, 423 Guardian Dr, Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA 19104-6021; e-mail: schmitz{at}mail.med.upenn.edu
Purpose A self-report measure of body image in female breast cancer survivors, the Body Image and Relationships Scale (BIRS), was developed to address attitudes about appearance, health, physical strength, sexuality, relationships, and social functioning following treatment. Methods The 32-item measure, generated by expert consensus and revised based on focus group feedback, was administered to 95 female breast cancer participants twice within 1 to 2 weeks. Test-retest reliability, internal consistency, and validity of the measure were assessed using standard-scale construction techniques. The structure of the proposed measure was evaluated using exploratory factor analysis. Associations of the resulting factors and other variables were assessed using extreme groups analyses. Results The BIRS had satisfactory test-retest reliability and internal consistency. Principal axis factoring revealed three factors: (1) health and strength, (2) social barriers, and (3) appearance and sexuality. Correlations of the subscales with standardized measures of related constructs were significant and in the anticipated directions. Extreme groups analyses suggested associations between less physical activity and more impairment on factors 1 and 3, premenopausal status at first diagnosis and more impairment on factor 2, and younger age at the time of survey administration and more impairment on factor 3. Conclusion The proposed scale demonstrated satisfactory reliability and internal consistency. Factor analysis revealed three subscales with coherent item content and differential associations with measures of activity level, menopause status, and age. Observed relationships with other measures support convergent and divergent validity. Results suggest that the proposed scale is useful for clinical and research applications.
The construct of body image has been evoked in relation to the physical and psychological changes associated with the treatment of breast cancer. Surgical therapies for breast cancer, including lumpectomy, mastectomy, and axillary lymph node dissection may be disfiguring and often traumatic. Mastectomies and reconstructive surgeries predict body image problems, especially in younger and sexually active women.1,2 Younger women who attribute more importance to body image than older patients tend to report lower body image satisfaction and poorer psychosocial adjustment after surgery.3 Body image is an important predictor of outcome, with measures of body image after breast cancer treatment explaining 59% of the variance in psychosocial adjustment.3 More positive body image perception correlates with higher self-efficacy in coping with breast cancer and its treatment,4 whereas heightened concern with body integrity predicts elevated distress, social disruption, and deterioration in feelings of sexual desirability.5,6 Breast cancer patients frequently experience sleep disturbances,7 and chemotherapy and radiotherapy can cause increased levels of fatigue.8,9 A decrease in sexual pleasure and dyspareunia was reported primarily in patients who underwent chemotherapy and radiotherapy, as well as surgery.10 A history of chemotherapy also has been associated with several late effects in breast cancer survivors. For example, chemotherapy and other postsurgical adjuvant therapies, such as tamoxifen, may cause menopausal symptoms among those diagnosed premenopausally.11 Decreased sexual desire has been reported by women diagnosed with early-stage as well as metastatic breast cancer, and is related to a high degree of concern about body integrity.6,12 Overall, previous research suggests that breast cancer treatment significantly impacts body image in female patients, and influences important long-term outcomes, including quality of life, sexuality, and psychosocial adjustment in survivors. However, to date, a disease-specific measure of body image in breast cancer survivors has not been developed. The need for such an instrument was noted in a completed exercise intervention study13 in which participating breast cancer survivors reported, anecdotally, that they experienced changes in body image as it related to social barriers, sense of strength and health, appearance, and sexuality. These survivors expressed frustration that the quality-of-life surveys administered pre- and postintervention did not adequately capture these important issues. When funded to conduct another exercise intervention study in breast cancer survivors (the ongoing Physical Activity and Lymphedema [PAL] trial), the researchers took the opportunity to develop a new survey to address these issues. This report describes the development and evaluation of the Body Image and Relationships Scale (BIRS) currently in use for the ongoing PAL trial.
Participants Twenty-one female breast cancer survivors were recruited through flyers posted at oncology clinics, notices placed in newsletters of cancer support organizations, and e-mails and letters sent to the address lists of local breast cancer support organizations (eg, the local Susan G. Komen chapter) to participate in focus groups to evaluate the initial version of a survey developed by the researchers. The 96 test-retest survey respondents were female long-term breast cancer survivors, recruited the same way as the focus groups. Participants were mostly white (95.8%), ranging in age from 37 to 77 years (mean, 56.9 years). All respondents had been diagnosed 5 to 15 years before participating in the study and self-reported being currently cancer free. Ninety-five of the participating women completed both surveys within 2 weeks. Focus-group participants received a $20 gift card for their 2-hour time commitment. Participants in the test-retest reliability assessment received a $15 gift card. All participants provided written informed consent for participation. The study was reviewed and approved by a University of Minnesota (Minneapolis, MN) human subjects protection program committee. All data collection and participant interaction took place at the University of Minnesota. The data analysis was conducted with a de-identified data set at the University of Pennsylvania.
Survey Items Preliminary versions of the questionnaire were revised with the help of the focus group participants. For example, questions about the impact of hot flashes on body image, social barriers, and sexuality were added based on focus group feedback. The revised survey was sent to five more breast cancer survivors, who completed the survey and underwent a brief telephone interview to answer questions similar to those used in the focus group discussions. Feedback from these five breast cancer survivors indicated that the survey addressed issues of importance to breast cancer survivors, that instructions and wording were clear, and that they felt comfortable answering all questions and were glad to have been asked about the issues in the survey. Based on these interviews, the only changes made were formatting changes. The resulting set of 32 items was administered via mail to the 96 study participants. Respondents were instructed to indicate on a five-point bipolar rating scale their agreement with each item (end points: 1 = disagree strongly, and 5 = agree strongly). Total scores were calculated by summing responses for all items. The scoring of individual items was reversed where appropriate so that higher scores indicated more impairment. As part of the larger PAL trial, respondents also provided basic demographic information and completed a battery of additional measures (Table 1), including the Coopersmith Self-Esteem Inventory, Pittsburgh Sleep-Quality Index, Fatigue Symptom Inventory, Medical Outcome Study Short Form and Social Support Scale, Pearlin's Social Mastery Scale, Life Orientation Test, Happiness Scale, Temporal-Satisfaction-with-Life Scale, Life Orientation Test, and a Quality-of-Life rating scale. These measures were designed to capture the various physiological and psychological sequelae of cancer diagnoses and treatments; all measures have admirable psychometric properties, including responsiveness to change, are readily scored and interpreted, may be self-administered via the mail, and are appropriate for adults across a broad spectrum of health states. All measures were completed twice, at the same time as participants completed the BIRS measure.
Statistical Analyses The sample size was initially determined based on estimates of the expected numbers of variables and factors. Post hoc power calculations indicate that even in settings with a low proportion of explained variance (communality), a sample size of 85 is adequate to ensure congruence of at least 0.98, assuming three factors with approximately 30 variables per factor.27
Data were analyzed using SPSS software (SPSS Inc, Chicago, IL). Test-retest reliability and internal consistency were assessed by calculating test-retest correlations and Cronbach's
Demographics A majority of participants were living with a partner (67.7%), but without children (72.0%). About two thirds of respondents had a college degree (60.4%). A majority of respondents reported an absence of current treatment for psychological difficulties (94.8%). Only 27.1% of respondents experienced any physical or mental health events during the year preceding the survey; 16.7% of respondents reported significant physical- or mental-health events. Most participants (80.2%) were currently physically active. Participants who exercised three times or more per week were less likely to report any physical or mental health events during the previous year (22.1% v 47.1%; 2 = 4.45; P = .07). At the time of their first diagnosis, 41.7% of respondents were premenopausal, 39.6% were postmenopausal, and 17.7% were perimenopausal. About two-thirds of respondents (61.5%) had experienced hot flashes and/or night sweats during the previous year. There was no significant difference between respondents who exercised more or less than three times a week in the prevalence of hot flashes.
Reliability and Internal Consistency
Principal Axis Factoring Principal axis factoring revealed the presence of eight factors with eigne values exceeding one; inspection of the scree plot revealed a clear break after the third factor. Based on Cattell's scree test, three factors were retained for further investigation.31 To aid the interpretation of these three factors, Varimax (orthogonal) rotation was performed. The rotated solution (Table 2) revealed the presence of simple structure, with all factors showing a number of strong loadings, and all but one variable loading substantially (at 0.40 or above) on only one component; the exception was item 20: "Sexual activity was an important part of my life," which loaded at only 0.28 on one factor. The three-factor solution explained a total of 52.9% of the variance, with factor 1 contributing 35.3%, factor 2 contributing 9.2%, and factor 3 contributing 8.4%. The three factors were significantly and positively correlated (Table 3). Results of another rotation, the direct Oblimin (oblique), were largely consistent with those described here. The only exception was item 5: "I felt like I had some control over how healthy I was," which loaded about equally onto factors 1 and 3.
The item content of the factors suggested the existence of three subscales, named strength and health, social barriers, and appearance and sexuality. Higher scores on each subscale indicated greater impairment. Factor 1, strength and health, assessed perceived physical impairment related to treatment, including decreased energy, feeling "weak" and "unhealthy," and lack of subjective control over health and strength. Twelve items loaded onto factor 1, for a maximum score of 60. Factor 2, social barriers, included nine items assessing perceived impairment in social interactions, including reduced social activity due to, and embarrassment about, physical or psychological symptoms, for a maximum score of 45. Finally, 11 items assessing decreased enjoyment of and satisfaction with sexual activity, embarrassment about physical appearance, and altered perception of one's body as "whole" and "natural" loaded onto factor 3, appearance and sexuality, for a maximum score of 55. Mean scores suggested relatively more impairment in appearance and sexuality (mean, 2.66; standard deviation [SD], 0.75) and strength and health (mean, 2.49; SD, 0.78) than social barriers (mean, 1.59; SD, 0.69). Similar results were obtained from a principal components analysis, which also indicated three factors; the one difference was that item 5: "I felt like I had some control over how healthy I was" loaded on factor 1 instead of factor 3.
Convergent and Divergent Validity
Scores on factor 1 assessing impairment in strength and health were strongly and inversely correlated with measures of quality of life, temporal life satisfaction, self-esteem, and happiness. Factor 1 correlated strongly and positively with measures of fatigue, personal mastery, and sleep quality. Negative correlations with measures of social support and optimism were somewhat weaker, as was a positive correlation with the pessimism subscale of the Life Orientation Test. Impairment in social functioning, as indicated by higher scores on factor 2, social barriers, correlated negatively and strongly with measures of self-esteem, quality of life, and life satisfaction, and less strongly with the optimism subscale of the Life Orientation Test, and happiness and social support scores. Factor 2 correlated strongly and positively with fatigue, and weakly with pessimism and sleep quality. Finally, high scores on factor 3 and impairment in the area of appearance and sexuality correlated strongly and inversely with measures of self-esteem, life satisfaction, and optimism. Negative correlations with social support, quality of life, and happiness were weaker, but still significant. Factor 3 correlated strongly and positively with scores on measures of personal mastery and pessimism, and somewhat more weakly and positively with measures of fatigue and sleep quality.
Extreme Groups Analyses
Respondents who reported currently exercising three times per week or more were significantly more likely to score lower on factor 1 strength and health (
Peri- and postmenopausal respondents scored significantly lower on factor 2, social barriers (
Women younger than age 50 years at the time of survey administration were more likely to score higher on appearance and sexuality (
This study aimed at developing a measure that captures experiences related to appearance, health, physical strength, sexuality, relationships, and social functioning that are unique to women diagnosed with, and treated for, breast cancer. These important issues had not been addressed in existing surveys. The proposed measure adequately reflects the experience of female breast cancer survivors, has acceptable psychometrics, and lends itself to future research in the field. Results suggest that the BIRS is an internally consistent, three-factor measure with good test-retest reliability. The scale produced expected correlations with measures of self-esteem, quality of life, personal mastery, and satisfaction with life, yet had good discriminant validity. Feedback from focus groups and respondents suggests good content validity, in that women felt the BIRS captured salient aspects of their experiences with regard to body image. Scales of the BIRS discriminated in predictable ways between women of different ages, menopause status, and levels of physical activity. Younger age was related to more impairment in sexual functioning and lower satisfaction with physical appearance. Having been peri- or postmenopausal at the time of the first diagnosis was related to less impairment in social functioning. Finally, women with higher levels of physical activity reported less impairment in physical strength and perceived control over their health. Two million breast cancer survivors are alive in the United States today. Previous research has focused primarily on treatment outcomes, such as rates of survival and recurrences; more recently, research has included the study of long-term effects of breast cancer treatment on outcomes such as quality of life.32-34 Research on psychosocial outcomes in breast cancer survivors has traditionally utilized broad measures of quality of life, which generally suggests adequate psychological and social functioning. However, anecdotal evidence, such as findings from our focus groups and a recent review,35 indicates that specific aspects of psychosocial adjustment and functioning after breast cancer diagnosis and treatment has not been appropriately captured by existing measures. Specifically, it appears that body image, sexuality, and appearance are all major psychosocial concerns for survivors that require disease-specific measures. As illustrated in this article, surgical and other treatments for breast cancer cause lasting changes in survivors physical appearance, sexuality, subjective well-being, and self-esteem. These changes can lead to impaired functioning in intimate relationships, lower perceived social support, and limited social activity. The BIRS addresses these aspects of survivorship and will likely provide a useful tool in future research on this topic, including as an outcome measure in studies investigating psychosocial functioning in terms of body image and relationships in breast cancer survivors, such as the ongoing PAL trial.
The author(s) indicated no potential conflicts of interest.
Conception and design: Leslie A. Lytle, Cynthia R. Gross, Rehana L. Ahmed, Kathryn H. Schmitz Administrative support: Rehana L. Ahmed, Kathryn H. Schmitz Provision of study materials or patients: Cynthia R. Gross, Rehana L. Ahmed, Kathryn H. Schmitz Collection and assembly of data: Cynthia R. Gross, Rehana L. Ahmed, Kathryn H. Schmitz Data analysis and interpretation: Julia M. Hormes, Leslie A. Lytle, Cynthia R. Gross, Rehana L. Ahmed, Andrea B. Troxel, Kathryn H. Schmitz Manuscript writing: Julia M. Hormes, Leslie A. Lytle, Cynthia R. Gross, Rehana L. Ahmed, Andrea B. Troxel, Kathryn H. Schmitz Final approval of manuscript: Leslie A. Lytle, Cynthia R. Gross, Rehana L. Ahmed, Andrea B. Troxel, Kathryn H. Schmitz
Supported by Grant No. R01-CA106851 from the National Cancer Institute. Authors disclosures of potential conflicts of interest and author contributions are found at the end of this article.
1. Mock V: Body image in women treated for breast cancer. Nurs Res 42:153-157, 1993[Medline] 2. Fobair P, Stewart SL, Chang S, et al: Body image and sexual problems in young women with breast cancer. Psychooncology 15:579-594, 2006[CrossRef][Medline] 3. Pecor MJ: The impact of breast cancer on body image in ethnically diverse women. Dissertation Abstracts International Section B 65:1036, 2004 4. Pikler V, Winterowd C: Racial and body image differences in coping for women diagnosed with breast cancer. Health Psychol 22:632-637, 2003[CrossRef][Medline] 5. Petronis VM, Carver CS, Antoni MH, et al: Investment in body image and psychosocial well-being among women treated for early stage breast cancer: Partial replication and extension. Psychol Health 18:1-13, 2003[CrossRef] 6. Carver CS, Pozo-Kaderman, Price AA, et al: Concern about aspects of body image and adjustment to early stage breast cancer. Psychosom Med 60:168-174, 1998 7. Palesh OG, Collie K, Batiuchok D, et al: A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol 75:37-44, 2007[CrossRef][Medline] 8. de Jong N, Kester ADM, Schouten HC, et al: Cause of fatigue between two cycles of adjuvant chemotherapy in breast cancer patients. Cancer Nurs 29:467-477, 2006[CrossRef][Medline] 9. Hann DM, Jacobsen P, Martin S, et al: Fatigue and quality of life following radiotherapy for breast cancer: A comparative study. J Clin Psychol Med S 5:19-33, 1998[CrossRef] 10. Patricelli N, Medina MC: Body image and sexuality in postsurgery breast cancer patients. Med Psicosom 49:85-92, 2004[Medline] 11. Downie FP, Mar Fan HG, Houede-Tchen, N, et al: Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: Evaluation with patient interview after formal assessment. Psychooncology 15:921-930, 2006[CrossRef][Medline] 12. Makar K, Cumming CE, Lees AW, et al: Sexuality, body image and quality of life after high dose or conventional chemotherapy for metastatic breast cancer. Can J Human Sexuality 6:1-8, 1997 13. Ohira T, Schmitz KH, Ahmed RL, et al: Effects of weight training on quality of life in recent breast cancer survivors. Cancer 106:2076-2083, 2006[CrossRef][Medline] 14. Coopersmith S: Self Esteem Inventories. Palo Alto, CA, Consulting Psychologists Press, 1981 15. Hann DM, Jacobsen PB, Azzarello LM, et al: Measurement of fatigue in cancer patients: Development and validation of the Fatigue Symptom Inventory. Qual Life Res 7:301-310, 1998[Medline] 16. Fordyce MW: A review of research on the happiness measures: A sixty second index of happiness and mental health. Social Indicators Res 20:355-381, 1988[CrossRef] 17. Scheier MF, Carver CS, Bridges MW: Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self esteem): A re-evaluation of the Life Orientation Test. J Pers Soc Psychol 67:1063-1078, 1994[CrossRef][Medline] 18. Sherbourne CD, Stewart AL: The MOS social support survey. Soc Sci Med 32:705-714, 1991[CrossRef][Medline] 19. Ware J, Kosinski M, Dewey J: How to score version 2 of the SF-36(R) Health Survey. Lincoln, RI, QualityMetric Inc, 2000 20. Tomich PL, Helgeson VS: Five years later: A cross-sectional comparison of breast cancer survivors with healthy women. Psychooncology 11:154-169, 2002[CrossRef][Medline] 21. Ganz PA, Desmond KA, Belin TR, et al: Predictors of sexual health in women after a breast cancer diagnosis. J Clin Oncol 17:2371-2380, 1999 22. Rowland JH, Desmond KA, Meyerowitz BE, et al: Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst 92:1422-1429, 2000 23. Pearlin LI, Schooler C: The structure of coping. J Health Soc Behav 19:2-21, 1978[Medline] 24. Buysse DJ, Reynolds CF, Monk TH, et al: The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 28:193-213, 1989[CrossRef][Medline] 25. Carpenter JS, Andrykowski MA: Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res 45:5-13, 1998[CrossRef][Medline] 26. Pavot W, Diener E, Suh E: The temporal satisfaction with life scale. J Pers Assess 70:340-354, 1998[CrossRef] 27. Mundfrom DJ, Shaw DG, Ke TL: Minimum sample size recommendations for conducting factor analysis. I J T 5:159-168, 2005 28. Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrika 16:297-334, 1951[CrossRef] 29. Kaiser H: An index of factorial simplicity. Psychometrika 39:31-36, 1974[CrossRef] 30. Bartlett MS: A note on multiplying factors for various chi square approximations. J R Stat Soc 16:296-298, 1954 31. Catell, RB: The scree test for number of factors. Multivar Behav Res 1:245-276, 1966[CrossRef] 32. Wilson RW, Hutson L, VanStry D: Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: The RAND 36-Item Health Survey and the Functional Living Index-Cancer. Phys Ther 85:851-860, 2005 33. Ganz PA, Desmond KA, Leedham B, et al: Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. J Natl Cancer Inst 94:39-49, 2002 34. Velanovich V, Szymanski W: Quality of life in breast cancer survivors with lymphedema. Am J Surg 177:184-188, 1999[CrossRef][Medline] 35. Goodwin PJ, Black JT, Beordeleau LJ, et al: Health-related quality-of-life measurement in randomized clinical trials in breast cancer: Taking stock. J Natl Cancer Inst 95:263-281, 2003 Submitted September 6, 2007; accepted November 16, 2007.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|